Two types of colistin heteroresistance in Acinetobacter baumannii isolates. 2020

Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
Department of Microbiology and Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.

In this study, we investigated the colistin heteroresistance patterns in Acinetobacter baumannii isolates. To identify colistin heteroresistance, population analysis profiling was performed for six in vitro colistin-susceptible A. baumannii isolates. Survival rates with and without prior exposure to colistin (at concentrations between 0 and 32 mg/L) were measured in media with and without colistin. Amino acid substitutions were also detected in colonies that survived in media with 4 mg/L colistin without further antibiotic treatment in six A. baumannii isolates. A stability test was also performed to investigate whether colistin resistance is maintained without antibiotic treatment. Although only three isolates showed typical colistin heteroresistance pattern, colistin-resistant populations were identified even without prior exposure to colistin in all A. baumannii isolates. Nearly all colonies of typical colistin-heteroresistant isolates (Type I heteroresistance) that survived after exposure to high colistin concentrations were found to be colistin-resistant, whereas no resistant colonies were identified in the other isolates (Type II heteroresistance). Stability tests showed that most of the surviving populations in media with 4 mg/L colistin without further antibiotic exposure failed to preserve resistance to colistin. Colistin-resistant populations also showed either no change in amino acid sequences, or diverse amino acid substitutions. We identified two types of colistin heteroresistance in A. baumannii isolates. Because Type I colistin-heteroresistant A. baumannii isolates could not be eradicated in vitro by high concentrations of colistin, differentiating two colistin heteroresistance types would be important for the treatment of A. baumannii infections using colistin.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003091 Colistin Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Polymyxin E,Colimycin,Colisticin,Colistin Sulfate,Coly-Mycin,Totazina,Sulfate, Colistin
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D000073537 Biological Variation, Population Differences in measurable biological values, characteristics, or traits, among individuals of a population or between population groups. Between-Individual Biological Variation,Between-Person Biological Variation,Between-Person Variation,Between-Subject Biological Variation,Between-Subject Variation,Biologic Variability, Population,Inter-Individual Biological Variation,Phenotypic Variability,Phenotypic Variation,Between Individual Biological Variation,Between Person Biological Variation,Between Person Variation,Between Subject Biological Variation,Between Subject Variation,Between-Individual Biological Variations,Between-Person Biological Variations,Between-Person Variations,Between-Subject Biological Variations,Between-Subject Variations,Biologic Variabilities, Population,Biological Variation, Between-Individual,Biological Variation, Between-Person,Biological Variation, Between-Subject,Biological Variation, Inter-Individual,Biological Variations, Between-Individual,Biological Variations, Between-Person,Biological Variations, Between-Subject,Biological Variations, Inter-Individual,Biological Variations, Population,Inter Individual Biological Variation,Inter-Individual Biological Variations,Phenotypic Variabilities,Phenotypic Variations,Population Biologic Variabilities,Population Biologic Variability,Population Biological Variation,Population Biological Variations,Variabilities, Phenotypic,Variabilities, Population Biologic,Variability, Phenotypic,Variability, Population Biologic,Variation, Between-Individual Biological,Variation, Between-Person,Variation, Between-Person Biological,Variation, Between-Subject,Variation, Between-Subject Biological,Variation, Inter-Individual Biological,Variation, Phenotypic,Variation, Population Biological,Variations, Between-Individual Biological,Variations, Between-Person,Variations, Between-Person Biological,Variations, Between-Subject,Variations, Between-Subject Biological,Variations, Inter-Individual Biological,Variations, Phenotypic,Variations, Population Biological
D000217 Acyltransferases Enzymes from the transferase class that catalyze the transfer of acyl groups from donor to acceptor, forming either esters or amides. (From Enzyme Nomenclature 1992) EC 2.3. Acyltransferase
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D050296 Microbial Viability Ability of a microbe to survive under given conditions. This can also be related to a colony's ability to replicate. Bacterial Viability,Virus Viability,Bacteria Viability,Microbial Inactivation,Inactivation, Microbial,Viability, Bacteria,Viability, Bacterial,Viability, Microbial,Viability, Virus
D018407 Bacterial Physiological Phenomena Physiological processes and properties of BACTERIA. Bacterial Physiology,Bacterial Processes,Bacterial Physiological Concepts,Bacterial Physiological Phenomenon,Bacterial Process,Physiology, Bacterial,Bacterial Physiological Concept,Concept, Bacterial Physiological,Concepts, Bacterial Physiological,Phenomena, Bacterial Physiological,Phenomenon, Bacterial Physiological,Process, Bacterial,Processes, Bacterial

Related Publications

Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
July 2020, The Journal of antibiotics,
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
June 2020, Acta microbiologica et immunologica Hungarica,
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
June 2018, Diagnostic microbiology and infectious disease,
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
September 2006, Antimicrobial agents and chemotherapy,
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
January 2019, Methods in molecular biology (Clifton, N.J.),
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
July 2020, World journal of microbiology & biotechnology,
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
December 2021, Microorganisms,
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
January 2012, The Journal of infection,
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
June 2020, Journal of global antimicrobial resistance,
Yoon-Kyoung Hong, and Hyunkeun Kim, and Kwan Soo Ko
March 2021, Microbial drug resistance (Larchmont, N.Y.),
Copied contents to your clipboard!